Literature DB >> 11814573

A low-background inducible promoter system in Leishmania donovani.

Shaofeng Yan1, Santiago Martinez-Calvillo, Achim Schnaufer, Susan Sunkin, Peter J Myler, Kenneth Stuart.   

Abstract

We report here a second-generation tetracycline-responsive repressor-operator system in Leishmania donovani. In this system, expression of a reporter luciferase gene (LUC) is driven by the inducible Leishmania ribosomal RNA promoter on the DNA strand opposite to a hygromycin resistance gene (HYG) whose expression is driven by the endogenous pol I promoter on chromosome 27 (rDNA locus) or the endogenous pol II promoter on chromosome 35 (LD1 locus). Transgenic cell lines showed regulation of LUC gene expression over three orders of magnitude. In the absence of tetracycline, luciferase expression levels were 2-3-fold higher than machine background when integrated into the LD1 locus, but was over 10-fold higher than machine background when integrated into the rDNA locus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814573     DOI: 10.1016/s0166-6851(01)00418-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

1.  Characterization of the RNA polymerase II and III complexes in Leishmania major.

Authors:  Santiago Martínez-Calvillo; Alka Saxena; Amanda Green; Aaron Leland; Peter J Myler
Journal:  Int J Parasitol       Date:  2006-12-19       Impact factor: 3.981

2.  Leishmania chagasi: a tetracycline-inducible cell line driven by T7 RNA polymerase.

Authors:  Chaoqun Yao; Jiwen Luo; Chia-Hung Christine Hsiao; John E Donelson; Mary E Wilson
Journal:  Exp Parasitol       Date:  2007-01-19       Impact factor: 2.011

3.  Transcription initiation and termination on Leishmania major chromosome 3.

Authors:  Santiago Martínez-Calvillo; Dan Nguyen; Kenneth Stuart; Peter J Myler
Journal:  Eukaryot Cell       Date:  2004-04

4.  A high-throughput cloning system for reverse genetics in Trypanosoma cruzi.

Authors:  Michel Batista; Fabricio K Marchini; Paola A F Celedon; Stenio P Fragoso; Christian M Probst; Henrique Preti; Luiz S Ozaki; Gregory A Buck; Samuel Goldenberg; Marco A Krieger
Journal:  BMC Microbiol       Date:  2010-10-13       Impact factor: 3.605

Review 5.  Transgenic Leishmania and the immune response to infection.

Authors:  L Beattie; K J Evans; P M Kaye; D F Smith
Journal:  Parasite Immunol       Date:  2008-02-04       Impact factor: 2.280

6.  Comparative genomic analysis of three Leishmania species that cause diverse human disease.

Authors:  Christopher S Peacock; Kathy Seeger; David Harris; Lee Murphy; Jeronimo C Ruiz; Michael A Quail; Nick Peters; Ellen Adlem; Adrian Tivey; Martin Aslett; Arnaud Kerhornou; Alasdair Ivens; Audrey Fraser; Marie-Adele Rajandream; Tim Carver; Halina Norbertczak; Tracey Chillingworth; Zahra Hance; Kay Jagels; Sharon Moule; Doug Ormond; Simon Rutter; Rob Squares; Sally Whitehead; Ester Rabbinowitsch; Claire Arrowsmith; Brian White; Scott Thurston; Frédéric Bringaud; Sandra L Baldauf; Adam Faulconbridge; Daniel Jeffares; Daniel P Depledge; Samuel O Oyola; James D Hilley; Loislene O Brito; Luiz R O Tosi; Barclay Barrell; Angela K Cruz; Jeremy C Mottram; Deborah F Smith; Matthew Berriman
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

7.  Simplified inducible system for Trypanosoma brucei.

Authors:  Gabriela T Niemirowicz; Juan J Cazzulo; Vanina E Álvarez; León A Bouvier
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.